Tetradecyl 2,3-dihydroxybenzoate alleviates oligodendrocyte damage following chronic cerebral hypoperfusion through IGF-1 receptor
Mahmoud I. Youssef, Yiting Zhou, Ibrahim H. Eissa, Yanhui Wang, Jing Zhang, Lei Jiang, Weiwei Hu, Jianhua Qi, Zhong Chen
Topics & Concepts
MedicineOligodendrocyteWhite matterNeuroprotectionInternal medicineRemyelinationReceptor antagonistVascular dementiaAnesthesiaCardiologyEndocrinologyPharmacologyAntagonistReceptorCentral nervous systemMyelinMagnetic resonance imagingDementiaRadiologyDiseaseNeurological Disease Mechanisms and TreatmentsNeurological Disorders and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms